uric acid has been researched along with HIV Coinfection in 16 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite the microbiological control in cryptococcal meningitis (CM), a proportion of previously healthy patients experience a clinical deterioration known as post-infectious inflammatory response syndrome (PIIRS)." | 1.91 | The effect of serum uric acid, bilirubin, and albumin levels on antioxidant status in HIV-negative immunocompetent cryptococcal meningitis patients with post-infectious inflammatory response syndrome. ( Fan, L; Jiang, Y; Liu, J; Ngai, IK; Peng, F; Su, Z; Wang, A; Xu, X; Yang, L; Yao, S, 2023) |
| "Uric acid and Zn were significantly higher, while vitamin E and all the trace elements (except Zn) were significantly lower in HIV-infected patients compared to healthy controls." | 1.34 | Essential trace elements and antioxidant status in relation to severity of HIV in Nigerian patients. ( Arinola, OG; Olaniyi, JA, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, A | 1 |
| Liu, J | 2 |
| Su, Z | 1 |
| Yao, S | 1 |
| Yang, L | 1 |
| Fan, L | 1 |
| Ngai, IK | 1 |
| Xu, X | 1 |
| Jiang, Y | 1 |
| Peng, F | 1 |
| Ahmadi-Motamayel, F | 1 |
| Amjad, SV | 1 |
| Goodarzi, MT | 1 |
| Poorolajal, J | 1 |
| Pirro, M | 1 |
| Bianconi, V | 1 |
| Schiaroli, E | 1 |
| Francisci, D | 1 |
| Mannarino, MR | 1 |
| Bagaglia, F | 1 |
| Sahebkar, A | 1 |
| Merriman, T | 1 |
| Baldelli, F | 1 |
| Hotta, MT | 1 |
| Broderick, E | 1 |
| Wyatt, CM | 1 |
| Chitra, P | 1 |
| Bakthavatsalam, B | 1 |
| Palvannan, T | 1 |
| Sundaram, M | 1 |
| Saghayam, S | 1 |
| Priya, B | 1 |
| Venkatesh, KK | 1 |
| Balakrishnan, P | 1 |
| Shankar, EM | 1 |
| Murugavel, KG | 1 |
| Solomon, S | 1 |
| Kumarasamy, N | 1 |
| Koblic, PM | 1 |
| Gold, WL | 1 |
| la Porte, CJ | 1 |
| Lee, TC | 1 |
| Lin, AL | 2 |
| Johnson, DA | 2 |
| Stephan, KT | 2 |
| Yeh, CK | 2 |
| Kinai, E | 1 |
| Hanabusa, H | 1 |
| Walker, UA | 1 |
| Hoffmann, C | 1 |
| Enters, M | 1 |
| Thoden, J | 1 |
| Behrens, G | 1 |
| Mitzel, SL | 1 |
| Sims, CA | 1 |
| Claas, GJ | 1 |
| Jülg, B | 1 |
| Goebel, FD | 1 |
| Bogner, J | 1 |
| Olaniyi, JA | 1 |
| Arinola, OG | 1 |
| Richardson, D | 1 |
| Liou, SH | 1 |
| Kahn, JO | 1 |
| Manfredi, R | 2 |
| Mastroianni, A | 1 |
| Coronado, OV | 1 |
| Chiodo, F | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment[NCT00000671] | Phase 2 | 750 participants | Interventional | Completed | |||
| Comparison of 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine in Therapy of Patients With HIV Infection[NCT00000979] | Phase 2 | 1,500 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for uric acid and HIV Coinfection
| Article | Year |
|---|---|
Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India.
Topics: Adult; Albumins; Alkynes; Anti-HIV Agents; Antioxidants; Antiretroviral Therapy, Highly Active; Benz | 2008 |
Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Cholesterol; Cholesterol, | 2007 |
Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.
Topics: Adult; Clinical Protocols; Cohort Studies; Didanosine; Double-Blind Method; Female; HIV Infections; | 1993 |
Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.
Topics: Adult; Clinical Protocols; Cohort Studies; Didanosine; Double-Blind Method; Female; HIV Infections; | 1993 |
Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.
Topics: Adult; Clinical Protocols; Cohort Studies; Didanosine; Double-Blind Method; Female; HIV Infections; | 1993 |
Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.
Topics: Adult; Clinical Protocols; Cohort Studies; Didanosine; Double-Blind Method; Female; HIV Infections; | 1993 |
13 other studies available for uric acid and HIV Coinfection
| Article | Year |
|---|---|
The effect of serum uric acid, bilirubin, and albumin levels on antioxidant status in HIV-negative immunocompetent cryptococcal meningitis patients with post-infectious inflammatory response syndrome.
Topics: Albumins; Animals; Antioxidants; Bilirubin; HIV Infections; Meningitis, Cryptococcal; Uric Acid | 2023 |
Evaluation of Salivary Uric Acid and pH in Human Immunodeficiency Virus Infected Patients: A Historical Cohort Study.
Topics: Adult; Antioxidants; Cohort Studies; Female; HIV Infections; Humans; Hydrogen-Ion Concentration; Ira | 2018 |
Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Biomarkers; Body Mass Index; Brachial Artery; Cr | 2018 |
Urine processing impacts uric acid level in HIV-infected adults: implications for diagnosing tenofovir-associated proximal tubulopathy.
Topics: Adenine; Adult; AIDS-Associated Nephropathy; Anti-HIV Agents; HIV Infections; Humans; Organophosphon | 2013 |
Osteonecrosis with renal damage in HIV patients undergoing HAART.
Topics: Antiretroviral Therapy, Highly Active; Arthritis, Rheumatoid; Creatinine; Cystatin C; HIV Infections | 2014 |
Medication-based urolithiasis and atazanavir.
Topics: Anti-Retroviral Agents; Atazanavir Sulfate; Dideoxynucleosides; Drug Therapy, Combination; HIV Infec | 2011 |
Alteration in salivary function in early HIV infection.
Topics: Adult; Albumins; Anti-HIV Agents; Calcium; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Imm | 2003 |
Renal tubular toxicity associated with tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels.
Topics: Absorption; Adenine; Adult; Alkaline Phosphatase; Antiretroviral Therapy, Highly Active; beta 2-Micr | 2005 |
High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters.
Topics: Adult; Aged; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Hyperuricemia; Male; Middle Age | 2006 |
Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART).
Topics: Adult; Analysis of Variance; Antiretroviral Therapy, Highly Active; Candida albicans; Case-Control S | 2006 |
Essential trace elements and antioxidant status in relation to severity of HIV in Nigerian patients.
Topics: Adolescent; Adult; Antioxidants; Bilirubin; Case-Control Studies; CD4 Lymphocyte Count; Female; HIV | 2007 |
Hyperuricemia and progression of HIV disease.
Topics: Adult; Aged; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; Humans; Male; Middle | 1996 |
Longitudinal assessment of serum urate levels as a marker of HIV disease progression.
Topics: Adult; Biomarkers; Disease Progression; Evaluation Studies as Topic; Female; Follow-Up Studies; HIV | 1998 |